Literature DB >> 8521389

Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene.

B Kazmierczak1, Y Hennig, S Wanschura, P Rogalla, S Bartnitzke, W Van de Ven, J Bullerdiek.   

Abstract

Aberrations involving the chromosomal region 12q24 are a nonrandom cytogenetic abnormality in frequent benign tumors mainly of mesenchymal origin, e.g., uterine leiomyomas, pleomorphic adenomas of the salivary gland, lipomas, or hamartomas of the lung. Mostly, these 12q24 abnormalities occur as a result of inversions also affecting chromosomal region 12q14-15. In addition to the frequent tumors mentioned above, these abnormalities have also been found in rare mesenchymal tumors, e.g., hemangiopericytomas. Although recently the molecular basis of the aberrations of chromosomal region 12q14-15, i.e., a rearrangement of the HMGI-C gene has been identified, the molecular roots of the 12q24 changes still remain to be elucidated. Herein we report on 3' rapid amplification of cDNA ends PCR results on cDNA from a primary uterine leiomyoma. As an ectopic sequence fused to exon 3 of the HMGI-C gene, we have identified a cDNA sequence that revealed 100% homology to exon 13 of the human mitochondrial aldehyde dehydrogenase gene (ALDH 2). Because ALDH 2 maps to 12q24.1, this fusion transcript is a good candidate underlying the chromosomal rearrangements involving 12q24.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521389

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors.

Authors:  B Kazmierczak; P Dal Cin; S Wanschura; S Bartnitzke; H Van den Berghe; J Bullerdiek
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 2.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

3.  HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors.

Authors:  P Rogalla; K Drechsler; G Frey; Y Hennig; B Helmke; U Bonk; J Bullerdiek
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.

Authors:  M Klotzbücher; A Wasserfall; U Fuhrmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma.

Authors:  S Xiao; M L Lux; R Reeves; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

Review 6.  The HMG I proteins: dynamic roles in gene activation, development, and tumorigenesis.

Authors:  F Liu; K Y Chau; P Arlotta; S J Ono
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

7.  High-mobility-group proteins and cancer--an emerging link.

Authors:  V Wunderlich; M Böttger
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

8.  Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma.

Authors:  Eva Röijer; Anders Nordkvist; Anna-Karin Ström; Walter Ryd; Margareta Behrendt; Jörn Bullerdiek; Joachim Mark; Göran Stenman
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

9.  Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.

Authors:  Xin Wu; Vanida A Serna; Justin Thomas; Wenan Qiang; Michael L Blumenfeld; Takeshi Kurita
Journal:  Cancer Res       Date:  2017-10-20       Impact factor: 12.701

10.  High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity.

Authors:  Lars Borrmann; Ralf Schwanbeck; Tomasz Heyduk; Birte Seebeck; Piere Rogalla; Jörn Bullerdiek; Jacek R Wisniewski
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.